Stop TB Partnership

Stop TB Partnership
Name	Stop TB Partnership
Formation	2001
Type	International partnership
Headquarters	Geneva, Switzerland
Region served	Worldwide
Leader title	Executive Secretary
Leader name	Lucica Ditiu
Parent organization	World Health Organization

Stop TB Partnership. The Stop TB Partnership is a global movement aimed at eliminating tuberculosis (TB) as a public health problem, working closely with the World Health Organization (WHO), United Nations Children's Fund (UNICEF), and other international organizations such as the Global Fund to Fight AIDS, Tuberculosis and Malaria. The partnership involves a wide range of stakeholders, including non-governmental organizations (NGOs) like Medecins Sans Frontieres (MSF) and Oxfam International, as well as governments, private sector companies, and academic institutions like Harvard University and the University of Oxford. The partnership's efforts are supported by donor agencies such as the Bill and Melinda Gates Foundation and the United States Agency for International Development (USAID).

Introduction

The Stop TB Partnership was established in 2001, with the goal of reducing the burden of TB worldwide, particularly in low- and middle-income countries like India, China, and South Africa. The partnership works to promote TB research, improve access to TB diagnosis and treatment, and strengthen health systems in countries like Brazil, Russia, and Indonesia. The partnership also collaborates with other global health initiatives, such as the Global Polio Eradication Initiative and the Measles and Rubella Initiative, to leverage resources and expertise. Key partners include UNAIDS, the World Bank, and the European Union.

History

The Stop TB Partnership was launched in response to the growing concern about the TB epidemic, particularly in sub-Saharan Africa and Southeast Asia. The partnership was established by a group of organizations, including the World Health Organization (WHO), the United Nations Development Programme (UNDP), and the World Bank, with the support of governments, NGOs, and the private sector. The partnership's early work focused on developing a Global Plan to Stop TB, which outlined a comprehensive strategy for reducing TB incidence and mortality. The plan was launched in 2001, with the support of Kofi Annan, the Secretary-General of the United Nations at the time, and has since been updated several times, with input from experts like Dr. Margaret Chan and Dr. Anthony Fauci.

Objectives

The Stop TB Partnership has several key objectives, including reducing TB incidence and mortality, improving access to TB diagnosis and treatment, and promoting TB research and development. The partnership also aims to strengthen health systems and improve the capacity of countries to respond to the TB epidemic, with support from organizations like the Centers for Disease Control and Prevention (CDC) and the European Centre for Disease Prevention and Control (ECDC). The partnership's objectives are aligned with the United Nations' Sustainable Development Goals (SDGs), particularly SDG 3, which aims to ensure healthy lives and promote well-being for all. The partnership works closely with other global health initiatives, such as the Roll Back Malaria Partnership and the Global Alliance for Vaccines and Immunization (GAVI), to achieve these objectives.

Membership_and_Governance

The Stop TB Partnership has a diverse membership, including governments, NGOs, private sector companies, and academic institutions. The partnership is governed by a Coordinating Board, which is responsible for setting the partnership's strategic direction and overseeing its activities. The Coordinating Board is composed of representatives from the partnership's member organizations, including the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), and the Global Fund to Fight AIDS, Tuberculosis and Malaria. The partnership also has a number of working groups and task forces, which focus on specific areas such as TB research and health systems strengthening. These groups are supported by experts from organizations like the National Institutes of Health (NIH) and the Wellcome Trust.

Activities_and_Initiatives

The Stop TB Partnership is involved in a wide range of activities and initiatives, including TB research and development, health systems strengthening, and advocacy and communication. The partnership works to promote access to TB diagnosis and treatment, particularly in low- and middle-income countries, with support from organizations like MSF and Oxfam International. The partnership also supports the development of new TB diagnostics and treatments, such as bedaquiline and delamanid, with funding from donor agencies like the Bill and Melinda Gates Foundation and the United States Agency for International Development (USAID). The partnership's activities are guided by its Global Plan to Stop TB, which outlines a comprehensive strategy for reducing TB incidence and mortality.

Impact_and_Achievements

The Stop TB Partnership has made significant progress in reducing the burden of TB worldwide. According to the World Health Organization (WHO), TB incidence has declined by 2% per year since 2000, and TB mortality has declined by 3% per year. The partnership's efforts have also led to significant improvements in access to TB diagnosis and treatment, particularly in low- and middle-income countries. The partnership has also supported the development of new TB diagnostics and treatments, such as bedaquiline and delamanid, which have improved treatment outcomes for people with multidrug-resistant TB (MDR-TB). The partnership's work has been recognized by global health leaders like Dr. Tedros Adhanom Ghebreyesus and Dr. Seth Berkley, and has received support from organizations like the European Union and the African Union.

Category:Global health